University of Geneva

Geneva 4, Switzerland


Purpose

to compare the tolerance and safety between a low-dose AZT containing regimen and a standard dosage in patients living with HIV/AIDS initiating antiretroviral therapy

Division

Global Health

Date

August 2011

Region Served

AFRICA

Committed amount

$109,853

Grant topic

HIV

Duration (months)

34

Grantee location

Geneva 4, Switzerland

Related work

HIV

More about our financials

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.